LFG
STOK icon

Larson Financial Group’s Stoke Therapeutics STOK Stock Holding History

Larson Financial Group’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.06K Buy
124
+7
+6% +$225 ﹤0.01% 2855
2026
Q1 		$3.81K Buy
117
+25
+27% +$820 ﹤0.01% 2726
2025
Q4 		$2.92K Sell
92
-22
-19% -$661 ﹤0.01% 2678
2025
Q3 		$2.68K Buy
114
+92
+418% +$1.58K ﹤0.01% 2591
2025
Q2 		$250 Sell
22
-16
-42% -$152 ﹤0.01% 3022
2025
Q1 		$253 Buy
+38
New +$354 ﹤0.01% 2737

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Larson Financial Group's STOK Position: Q2 2026 in Review

Larson Financial Group increased its Stoke Therapeutics (STOK) stake by 6% in Q2 2026, buying an estimated $225 and bringing the position to 124 shares worth $4.06K. The position accounts for ﹤0.01% of the portfolio, ranked #2855.

Larson Financial Group first reported a position in STOK in Q1 2025 and has held it in 6 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Larson Financial Group held 124 shares of Stoke Therapeutics worth $4.06K as of Q2 2026.
  • Larson Financial Group bought 7 Stoke Therapeutics shares in Q2 2026, an estimated $225.
  • Stoke Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2855 holding.
  • Larson Financial Group first reported a position in Stoke Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.